Philip T - Search Results

1

Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.

Favrot M, Capdeville R, Combaret V, Zhou DC, Clapisson G, Banchereau J, Franks CR, Chouaib S, Blay JY, Philip T. Favrot M, et al. Among authors: philip t. Eur Cytokine Netw. 1990 Aug-Sep;1(3):141-7. Eur Cytokine Netw. 1990. PMID: 2129798

2

Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinoma.

Favrot MC, Combaret V, Negrier S, Philip I, Thiesse P, Freydel C, Bijmann JT, Franks CR, Mercatello A, Philip T. Favrot MC, et al. Among authors: philip i, philip t. J Biol Response Mod. 1990 Apr;9(2):167-77. J Biol Response Mod. 1990. PMID: 1971303

3

TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.

Favrot M, Combaret V, Blay JY, Capdeville R, Zhou DC, Clapisson G, Chouaib S, Franks CR, Philip T. Favrot M, et al. Among authors: philip t. Eur Cytokine Netw. 1990 Oct-Nov;1(4):221-7. Eur Cytokine Netw. 1990. PMID: 2104243

4

Lymphokine-activated killer cell expansion for clinical trials of adoptive immunotherapy with interleukin-2: optimization of the culture technique.

Favrot MC, Coze C, Combaret V, Gaspard M, Colin C, Franks C, Negrier S, Philip I, Philip T. Favrot MC, et al. Among authors: philip i, philip t. Mol Biother. 1990 Mar;2(1):32-7. Mol Biother. 1990. PMID: 2185792 Clinical Trial.

5

[Adoptive immunotherapy with interleukin 2 in oncology].

Favrot M, Bouffet E, Négrier S, Combaret V, Philip I, Philip T. Favrot M, et al. Among authors: philip i, philip t. Bull Cancer. 1990;77(9):925-31. Bull Cancer. 1990. PMID: 2224165 Clinical Trial. French.

6

Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor.

Blay JY, Favrot MC, Negrier S, Combaret V, Chouaib S, Mercatello A, Kaemmerlen P, Franks CR, Philip T. Blay JY, et al. Among authors: philip t. Cancer Res. 1990 Apr 15;50(8):2371-4. Cancer Res. 1990. PMID: 2317822

7

Analysis of parameters for maximal in vitro proliferation and activation of lymphokine-activated killer cells (LAK).

Coze C, Combaret V, Philip I, Négrier S, Colin C, Gaspard M, Franks CR, Bijman JT, Philip T, Favrot M. Coze C, et al. Among authors: philip i, philip t. Nouv Rev Fr Hematol (1978). 1989;31(5):339-43. Nouv Rev Fr Hematol (1978). 1989. PMID: 2587202

8

High-dose chemotherapy in non-Hodgkin's lymphoma.

Blay JY, Philip TO. Blay JY, et al. Among authors: philip to. Cancer Treat Res. 1996;85:87-103. doi: 10.1007/978-1-4615-4129-5_7. Cancer Treat Res. 1996. PMID: 9043777 Review. No abstract available.

9

Immunomagnetic depletion of malignant cells from autologous bone marrow graft: from experimental models to clinical trials.

Combaret V, Favrot MC, Chauvin F, Bouffet E, Philip I, Philip T. Combaret V, et al. Among authors: philip i, philip t. J Immunogenet. 1989 Apr;16(2):125-36. doi: 10.1111/j.1744-313x.1989.tb00454.x. J Immunogenet. 1989. PMID: 2687382 Clinical Trial.

10

S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft.

Combaret V, Kremens B, Favrot MC, Laurent JC, Philip T. Combaret V, et al. Among authors: philip t. Bone Marrow Transplant. 1988 May;3(3):221-7. Bone Marrow Transplant. 1988. PMID: 2844344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters